Data / Form D filings / Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc.: Form D filings
Rhythm Pharmaceuticals, Inc., a pharmaceuticals company in Boston, MA, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on December 4, 2012, reports $22.5 million sold of a $42.5 million offering to 6 investors.
Find out what Rhythm Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 855 Boylston Street, 11th Floor, Boston, MA, 02116
- Phone
- (617) 428-6390
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1483887
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2012 | Amendment | $42,500,000 | $22,500,000 | $20,000,000 | 6 | May 25, 2012 | sec.gov |
| Jun 4, 2012 | New notice | $34,500,000 | $9,500,000 | $25,000,000 | 4 | May 25, 2012 | sec.gov |
| Aug 30, 2010 | Amendment | $40,000,000 | $18,000,000 | $22,000,000 | 4 | Mar 9, 2010 | sec.gov |
| Mar 22, 2010 | New notice | $21,000,000 | $10,000,000 | $11,000,000 | 3 | Mar 9, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keith Gottesdiener | Executive Officer, Director | |
| Edward Mathers | Director | |
| Bart Henderson | Executive Officer | |
| Vaughan Kailian | Director | |
| Christian De La Tour | Director | |
| Lou Tartaglia | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Dec 3, 2012 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Rhythm Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.